Literature DB >> 2211966

Primary neonatal hyperparathyroidism: a devastating neurodevelopmental disorder if left untreated.

D e Cole1, C R Forsythe, J M Dooley, E B Grantmyre, S R Salisbury.   

Abstract

We describe a 29-year-old male with untreated primary neonatal hyperparathyroidism. Hypotonia, poor feeding, failure to thrive, and developmental delay were noted in early infancy and in incidental serum calcium of 3.8 mmol/L was dismissed as a laboratory error. Childhood was characterized by profound muscle wasting and progressive spastic quadriparesis. Distinctive skeletal deformities, facial dysmorphism, and perichondral calcifications are now evident in adulthood. Elevated serum calcium (range: 2.7-3.3 mM; normal less than 2.7 mM), serum immunoreactive parathyroid hormone (range: 1,405-1,817 pg/mL; normal 50-140 pg/mL), and markedly decreased urinary calcium excretion (0.04 mumol/dL glomerular filtrate; normal greater than 25) suggested the diagnosis of primary neonatal hyperparathyroidism. This was supported by evidence of hypocalciuric hypercalcemia--the autosomal dominant carrier state--in both the parents. Our case illustrates the profound neurodevelopmental deficits arising from sustained hypercalcemia in infancy and childhood. Although this disorder is not lethal, it should be considered a neonatal emergency, since surgical parathyroidectomy can result in cure.

Entities:  

Mesh:

Year:  1990        PMID: 2211966

Source DB:  PubMed          Journal:  J Craniofac Genet Dev Biol        ISSN: 0270-4145


  15 in total

Review 1.  Familial hypocalciuric hypercalcemia.

Authors:  D A Heath
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

3.  Neonatal severe hyperparathyroidism: further clinical and molecular delineation.

Authors:  Fawziya A Al-Khalaf; Adel Ismail; Ashraf T Soliman; David E C Cole; Tawfeg Ben-Omran
Journal:  Eur J Pediatr       Date:  2010-10-23       Impact factor: 3.183

Review 4.  Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.

Authors:  Anthony W Gannon; Heather M Monk; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

5.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

6.  Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M Bai; N Janicic; S Trivedi; S J Quinn; D E Cole; E M Brown; G N Hendy
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

7.  Sensory Axon Growth Requires Spatiotemporal Integration of CaSR and TrkB Signaling.

Authors:  Ronja Markworth; Youri Adolfs; Vivian Dambeck; Lars M Steinbeck; Muriel Lizé; R Jeroen Pasterkamp; Mathias Bähr; Camin Dean; Katja Burk
Journal:  J Neurosci       Date:  2019-05-23       Impact factor: 6.167

8.  A novel CASR mutation in a Tunisian FHH/NSHPT family associated with a mental retardation.

Authors:  Sana Sfar; Ahlem Afaya Bzéouich; Emna Kerkeni; Sofiane Bouaziz; Mohamed Fadhel Najjar; Lotfi Chouchane; Kamel Monastiri
Journal:  Mol Biol Rep       Date:  2011-06-12       Impact factor: 2.316

9.  A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.

Authors:  Steven A Lietman; Yardena Tenenbaum-Rakover; Tjin Shing Jap; Wu Yi-Chi; Yang De-Ming; Changlin Ding; Najat Kussiny; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2009-09-29       Impact factor: 5.958

10.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.